Global Pharmaceutical Excipients for Oral Formulations Market Growth 2025-2031
The global Pharmaceutical Excipients for Oral Formulations market size is predicted to grow from US$ 54980 million in 2025 to US$ 73160 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pharmaceutical excipients that deliver the full potential of your drug and improve patient compliance.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients for Oral Formulations Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients for Oral Formulations sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients for Oral Formulations sales for 2025 through 2031. With Pharmaceutical Excipients for Oral Formulations sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients for Oral Formulations industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients for Oral Formulations landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients for Oral Formulations portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients for Oral Formulations market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients for Oral Formulations and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients for Oral Formulations.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients for Oral Formulations market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pharmaceutical Excipients for Oral Formulations market?
What factors are driving Pharmaceutical Excipients for Oral Formulations market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Excipients for Oral Formulations market opportunities vary by end market size?
How does Pharmaceutical Excipients for Oral Formulations break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pharmaceutical excipients that deliver the full potential of your drug and improve patient compliance.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients for Oral Formulations Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients for Oral Formulations sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients for Oral Formulations sales for 2025 through 2031. With Pharmaceutical Excipients for Oral Formulations sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients for Oral Formulations industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients for Oral Formulations landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients for Oral Formulations portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients for Oral Formulations market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients for Oral Formulations and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients for Oral Formulations.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients for Oral Formulations market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tablets
- Capsules
- Hospital Pharmacies
- Drug Stores
- Retail Stores
- E-Commerce
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BASF
- DowDupont
- Roquette
- Evonik Industries
- Lubrizol
- Archer Daniels Midland
What is the 10-year outlook for the global Pharmaceutical Excipients for Oral Formulations market?
What factors are driving Pharmaceutical Excipients for Oral Formulations market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Excipients for Oral Formulations market opportunities vary by end market size?
How does Pharmaceutical Excipients for Oral Formulations break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Oral Formulations by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Oral Formulations by Country/Region, 2020, 2024 & 2031
2.2 Pharmaceutical Excipients for Oral Formulations Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Pharmaceutical Excipients for Oral Formulations Sales by Type
2.3.1 Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
2.3.2 Global Pharmaceutical Excipients for Oral Formulations Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharmaceutical Excipients for Oral Formulations Sale Price by Type (2020-2025)
2.4 Pharmaceutical Excipients for Oral Formulations Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Retail Stores
2.4.4 E-Commerce
2.5 Pharmaceutical Excipients for Oral Formulations Sales by Application
2.5.1 Global Pharmaceutical Excipients for Oral Formulations Sale Market Share by Application (2020-2025)
2.5.2 Global Pharmaceutical Excipients for Oral Formulations Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharmaceutical Excipients for Oral Formulations Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Excipients for Oral Formulations Breakdown Data by Company
3.1.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales by Company (2020-2025)
3.1.2 Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Company (2020-2025)
3.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue by Company (2020-2025)
3.2.1 Global Pharmaceutical Excipients for Oral Formulations Revenue by Company (2020-2025)
3.2.2 Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Company (2020-2025)
3.3 Global Pharmaceutical Excipients for Oral Formulations Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Excipients for Oral Formulations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Excipients for Oral Formulations Product Location Distribution
3.4.2 Players Pharmaceutical Excipients for Oral Formulations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR ORAL FORMULATIONS BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Excipients for Oral Formulations Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharmaceutical Excipients for Oral Formulations Market Size by Country/Region (2020-2025)
4.2.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Excipients for Oral Formulations Sales Growth
4.4 APAC Pharmaceutical Excipients for Oral Formulations Sales Growth
4.5 Europe Pharmaceutical Excipients for Oral Formulations Sales Growth
4.6 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Excipients for Oral Formulations Sales by Country
5.1.1 Americas Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025)
5.1.2 Americas Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025)
5.2 Americas Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
5.3 Americas Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Excipients for Oral Formulations Sales by Region
6.1.1 APAC Pharmaceutical Excipients for Oral Formulations Sales by Region (2020-2025)
6.1.2 APAC Pharmaceutical Excipients for Oral Formulations Revenue by Region (2020-2025)
6.2 APAC Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
6.3 APAC Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Excipients for Oral Formulations by Country
7.1.1 Europe Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025)
7.1.2 Europe Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025)
7.2 Europe Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
7.3 Europe Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Excipients for Oral Formulations by Country
8.1.1 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Oral Formulations
10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Oral Formulations
10.4 Industry Chain Structure of Pharmaceutical Excipients for Oral Formulations
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Excipients for Oral Formulations Distributors
11.3 Pharmaceutical Excipients for Oral Formulations Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR ORAL FORMULATIONS BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Excipients for Oral Formulations Market Size Forecast by Region
12.1.1 Global Pharmaceutical Excipients for Oral Formulations Forecast by Region (2026-2031)
12.1.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharmaceutical Excipients for Oral Formulations Forecast by Type (2026-2031)
12.7 Global Pharmaceutical Excipients for Oral Formulations Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.1.3 BASF Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 DowDupont
13.2.1 DowDupont Company Information
13.2.2 DowDupont Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.2.3 DowDupont Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 DowDupont Main Business Overview
13.2.5 DowDupont Latest Developments
13.3 Roquette
13.3.1 Roquette Company Information
13.3.2 Roquette Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.3.3 Roquette Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roquette Main Business Overview
13.3.5 Roquette Latest Developments
13.4 Evonik Industries
13.4.1 Evonik Industries Company Information
13.4.2 Evonik Industries Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.4.3 Evonik Industries Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Evonik Industries Main Business Overview
13.4.5 Evonik Industries Latest Developments
13.5 Lubrizol
13.5.1 Lubrizol Company Information
13.5.2 Lubrizol Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.5.3 Lubrizol Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lubrizol Main Business Overview
13.5.5 Lubrizol Latest Developments
13.6 Archer Daniels Midland
13.6.1 Archer Daniels Midland Company Information
13.6.2 Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.6.3 Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Archer Daniels Midland Main Business Overview
13.6.5 Archer Daniels Midland Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Oral Formulations by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Oral Formulations by Country/Region, 2020, 2024 & 2031
2.2 Pharmaceutical Excipients for Oral Formulations Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Pharmaceutical Excipients for Oral Formulations Sales by Type
2.3.1 Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
2.3.2 Global Pharmaceutical Excipients for Oral Formulations Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharmaceutical Excipients for Oral Formulations Sale Price by Type (2020-2025)
2.4 Pharmaceutical Excipients for Oral Formulations Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Retail Stores
2.4.4 E-Commerce
2.5 Pharmaceutical Excipients for Oral Formulations Sales by Application
2.5.1 Global Pharmaceutical Excipients for Oral Formulations Sale Market Share by Application (2020-2025)
2.5.2 Global Pharmaceutical Excipients for Oral Formulations Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharmaceutical Excipients for Oral Formulations Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Excipients for Oral Formulations Breakdown Data by Company
3.1.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales by Company (2020-2025)
3.1.2 Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Company (2020-2025)
3.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue by Company (2020-2025)
3.2.1 Global Pharmaceutical Excipients for Oral Formulations Revenue by Company (2020-2025)
3.2.2 Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Company (2020-2025)
3.3 Global Pharmaceutical Excipients for Oral Formulations Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Excipients for Oral Formulations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Excipients for Oral Formulations Product Location Distribution
3.4.2 Players Pharmaceutical Excipients for Oral Formulations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR ORAL FORMULATIONS BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Excipients for Oral Formulations Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharmaceutical Excipients for Oral Formulations Market Size by Country/Region (2020-2025)
4.2.1 Global Pharmaceutical Excipients for Oral Formulations Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Excipients for Oral Formulations Sales Growth
4.4 APAC Pharmaceutical Excipients for Oral Formulations Sales Growth
4.5 Europe Pharmaceutical Excipients for Oral Formulations Sales Growth
4.6 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Excipients for Oral Formulations Sales by Country
5.1.1 Americas Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025)
5.1.2 Americas Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025)
5.2 Americas Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
5.3 Americas Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Excipients for Oral Formulations Sales by Region
6.1.1 APAC Pharmaceutical Excipients for Oral Formulations Sales by Region (2020-2025)
6.1.2 APAC Pharmaceutical Excipients for Oral Formulations Revenue by Region (2020-2025)
6.2 APAC Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
6.3 APAC Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Excipients for Oral Formulations by Country
7.1.1 Europe Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025)
7.1.2 Europe Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025)
7.2 Europe Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
7.3 Europe Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Excipients for Oral Formulations by Country
8.1.1 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Oral Formulations
10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Oral Formulations
10.4 Industry Chain Structure of Pharmaceutical Excipients for Oral Formulations
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Excipients for Oral Formulations Distributors
11.3 Pharmaceutical Excipients for Oral Formulations Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL EXCIPIENTS FOR ORAL FORMULATIONS BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Excipients for Oral Formulations Market Size Forecast by Region
12.1.1 Global Pharmaceutical Excipients for Oral Formulations Forecast by Region (2026-2031)
12.1.2 Global Pharmaceutical Excipients for Oral Formulations Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharmaceutical Excipients for Oral Formulations Forecast by Type (2026-2031)
12.7 Global Pharmaceutical Excipients for Oral Formulations Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.1.3 BASF Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 DowDupont
13.2.1 DowDupont Company Information
13.2.2 DowDupont Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.2.3 DowDupont Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 DowDupont Main Business Overview
13.2.5 DowDupont Latest Developments
13.3 Roquette
13.3.1 Roquette Company Information
13.3.2 Roquette Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.3.3 Roquette Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roquette Main Business Overview
13.3.5 Roquette Latest Developments
13.4 Evonik Industries
13.4.1 Evonik Industries Company Information
13.4.2 Evonik Industries Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.4.3 Evonik Industries Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Evonik Industries Main Business Overview
13.4.5 Evonik Industries Latest Developments
13.5 Lubrizol
13.5.1 Lubrizol Company Information
13.5.2 Lubrizol Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.5.3 Lubrizol Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lubrizol Main Business Overview
13.5.5 Lubrizol Latest Developments
13.6 Archer Daniels Midland
13.6.1 Archer Daniels Midland Company Information
13.6.2 Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
13.6.3 Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Archer Daniels Midland Main Business Overview
13.6.5 Archer Daniels Midland Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical Excipients for Oral Formulations Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pharmaceutical Excipients for Oral Formulations Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Global Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 6. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Table 7. Global Pharmaceutical Excipients for Oral Formulations Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2020-2025)
Table 9. Global Pharmaceutical Excipients for Oral Formulations Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Pharmaceutical Excipients for Oral Formulations Sale by Application (2020-2025) & (K Units)
Table 11. Global Pharmaceutical Excipients for Oral Formulations Sale Market Share by Application (2020-2025)
Table 12. Global Pharmaceutical Excipients for Oral Formulations Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application (2020-2025)
Table 14. Global Pharmaceutical Excipients for Oral Formulations Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pharmaceutical Excipients for Oral Formulations Sales by Company (2020-2025) & (K Units)
Table 16. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Company (2020-2025)
Table 17. Global Pharmaceutical Excipients for Oral Formulations Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Company (2020-2025)
Table 19. Global Pharmaceutical Excipients for Oral Formulations Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pharmaceutical Excipients for Oral Formulations Producing Area Distribution and Sales Area
Table 21. Players Pharmaceutical Excipients for Oral Formulations Products Offered
Table 22. Pharmaceutical Excipients for Oral Formulations Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pharmaceutical Excipients for Oral Formulations Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pharmaceutical Excipients for Oral Formulations Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pharmaceutical Excipients for Oral Formulations Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pharmaceutical Excipients for Oral Formulations Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025) & (K Units)
Table 34. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2020-2025)
Table 35. Americas Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 37. Americas Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 38. APAC Pharmaceutical Excipients for Oral Formulations Sales by Region (2020-2025) & (K Units)
Table 39. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Region (2020-2025)
Table 40. APAC Pharmaceutical Excipients for Oral Formulations Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 42. APAC Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 43. Europe Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025) & (K Units)
Table 44. Europe Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 46. Europe Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients for Oral Formulations
Table 52. Key Market Challenges & Risks of Pharmaceutical Excipients for Oral Formulations
Table 53. Key Industry Trends of Pharmaceutical Excipients for Oral Formulations
Table 54. Pharmaceutical Excipients for Oral Formulations Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pharmaceutical Excipients for Oral Formulations Distributors List
Table 57. Pharmaceutical Excipients for Oral Formulations Customer List
Table 58. Global Pharmaceutical Excipients for Oral Formulations Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pharmaceutical Excipients for Oral Formulations Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Pharmaceutical Excipients for Oral Formulations Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pharmaceutical Excipients for Oral Formulations Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Pharmaceutical Excipients for Oral Formulations Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pharmaceutical Excipients for Oral Formulations Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pharmaceutical Excipients for Oral Formulations Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pharmaceutical Excipients for Oral Formulations Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. BASF Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 73. BASF Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 74. BASF Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. BASF Main Business
Table 76. BASF Latest Developments
Table 77. DowDupont Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 78. DowDupont Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 79. DowDupont Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. DowDupont Main Business
Table 81. DowDupont Latest Developments
Table 82. Roquette Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 83. Roquette Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 84. Roquette Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Roquette Main Business
Table 86. Roquette Latest Developments
Table 87. Evonik Industries Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 88. Evonik Industries Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 89. Evonik Industries Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Evonik Industries Main Business
Table 91. Evonik Industries Latest Developments
Table 92. Lubrizol Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 93. Lubrizol Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 94. Lubrizol Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Lubrizol Main Business
Table 96. Lubrizol Latest Developments
Table 97. Archer Daniels Midland Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 98. Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 99. Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Archer Daniels Midland Main Business
Table 101. Archer Daniels Midland Latest Developments
Table 1. Pharmaceutical Excipients for Oral Formulations Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pharmaceutical Excipients for Oral Formulations Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Global Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 6. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Table 7. Global Pharmaceutical Excipients for Oral Formulations Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2020-2025)
Table 9. Global Pharmaceutical Excipients for Oral Formulations Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Pharmaceutical Excipients for Oral Formulations Sale by Application (2020-2025) & (K Units)
Table 11. Global Pharmaceutical Excipients for Oral Formulations Sale Market Share by Application (2020-2025)
Table 12. Global Pharmaceutical Excipients for Oral Formulations Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application (2020-2025)
Table 14. Global Pharmaceutical Excipients for Oral Formulations Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pharmaceutical Excipients for Oral Formulations Sales by Company (2020-2025) & (K Units)
Table 16. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Company (2020-2025)
Table 17. Global Pharmaceutical Excipients for Oral Formulations Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Company (2020-2025)
Table 19. Global Pharmaceutical Excipients for Oral Formulations Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pharmaceutical Excipients for Oral Formulations Producing Area Distribution and Sales Area
Table 21. Players Pharmaceutical Excipients for Oral Formulations Products Offered
Table 22. Pharmaceutical Excipients for Oral Formulations Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pharmaceutical Excipients for Oral Formulations Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pharmaceutical Excipients for Oral Formulations Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pharmaceutical Excipients for Oral Formulations Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pharmaceutical Excipients for Oral Formulations Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025) & (K Units)
Table 34. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2020-2025)
Table 35. Americas Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 37. Americas Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 38. APAC Pharmaceutical Excipients for Oral Formulations Sales by Region (2020-2025) & (K Units)
Table 39. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Region (2020-2025)
Table 40. APAC Pharmaceutical Excipients for Oral Formulations Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 42. APAC Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 43. Europe Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025) & (K Units)
Table 44. Europe Pharmaceutical Excipients for Oral Formulations Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 46. Europe Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients for Oral Formulations
Table 52. Key Market Challenges & Risks of Pharmaceutical Excipients for Oral Formulations
Table 53. Key Industry Trends of Pharmaceutical Excipients for Oral Formulations
Table 54. Pharmaceutical Excipients for Oral Formulations Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pharmaceutical Excipients for Oral Formulations Distributors List
Table 57. Pharmaceutical Excipients for Oral Formulations Customer List
Table 58. Global Pharmaceutical Excipients for Oral Formulations Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pharmaceutical Excipients for Oral Formulations Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Pharmaceutical Excipients for Oral Formulations Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pharmaceutical Excipients for Oral Formulations Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Pharmaceutical Excipients for Oral Formulations Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pharmaceutical Excipients for Oral Formulations Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pharmaceutical Excipients for Oral Formulations Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pharmaceutical Excipients for Oral Formulations Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Pharmaceutical Excipients for Oral Formulations Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. BASF Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 73. BASF Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 74. BASF Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. BASF Main Business
Table 76. BASF Latest Developments
Table 77. DowDupont Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 78. DowDupont Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 79. DowDupont Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. DowDupont Main Business
Table 81. DowDupont Latest Developments
Table 82. Roquette Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 83. Roquette Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 84. Roquette Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Roquette Main Business
Table 86. Roquette Latest Developments
Table 87. Evonik Industries Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 88. Evonik Industries Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 89. Evonik Industries Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Evonik Industries Main Business
Table 91. Evonik Industries Latest Developments
Table 92. Lubrizol Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 93. Lubrizol Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 94. Lubrizol Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Lubrizol Main Business
Table 96. Lubrizol Latest Developments
Table 97. Archer Daniels Midland Basic Information, Pharmaceutical Excipients for Oral Formulations Manufacturing Base, Sales Area and Its Competitors
Table 98. Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Product Portfolios and Specifications
Table 99. Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Archer Daniels Midland Main Business
Table 101. Archer Daniels Midland Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pharmaceutical Excipients for Oral Formulations
Figure 2. Pharmaceutical Excipients for Oral Formulations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Excipients for Oral Formulations Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pharmaceutical Excipients for Oral Formulations Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pharmaceutical Excipients for Oral Formulations Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country/Region (2024)
Figure 10. Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type in 2025
Figure 14. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2020-2025)
Figure 15. Pharmaceutical Excipients for Oral Formulations Consumed in Hospital Pharmacies
Figure 16. Global Pharmaceutical Excipients for Oral Formulations Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 17. Pharmaceutical Excipients for Oral Formulations Consumed in Drug Stores
Figure 18. Global Pharmaceutical Excipients for Oral Formulations Market: Drug Stores (2020-2025) & (K Units)
Figure 19. Pharmaceutical Excipients for Oral Formulations Consumed in Retail Stores
Figure 20. Global Pharmaceutical Excipients for Oral Formulations Market: Retail Stores (2020-2025) & (K Units)
Figure 21. Pharmaceutical Excipients for Oral Formulations Consumed in E-Commerce
Figure 22. Global Pharmaceutical Excipients for Oral Formulations Market: E-Commerce (2020-2025) & (K Units)
Figure 23. Global Pharmaceutical Excipients for Oral Formulations Sale Market Share by Application (2024)
Figure 24. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application in 2025
Figure 25. Pharmaceutical Excipients for Oral Formulations Sales by Company in 2025 (K Units)
Figure 26. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Company in 2025
Figure 27. Pharmaceutical Excipients for Oral Formulations Revenue by Company in 2025 ($ millions)
Figure 28. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Company in 2025
Figure 29. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 32. Americas Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 33. APAC Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 34. APAC Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 35. Europe Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 36. Europe Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 39. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country in 2025
Figure 40. Americas Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country (2020-2025)
Figure 41. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 42. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 43. United States Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Region in 2025
Figure 48. APAC Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Region (2020-2025)
Figure 49. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 50. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 51. China Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 55. India Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country in 2025
Figure 59. Europe Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country (2020-2025)
Figure 60. Europe Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 61. Europe Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 62. Germany Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 63. France Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 70. Egypt Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Oral Formulations in 2025
Figure 76. Manufacturing Process Analysis of Pharmaceutical Excipients for Oral Formulations
Figure 77. Industry Chain Structure of Pharmaceutical Excipients for Oral Formulations
Figure 78. Channels of Distribution
Figure 79. Global Pharmaceutical Excipients for Oral Formulations Sales Market Forecast by Region (2026-2031)
Figure 80. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Pharmaceutical Excipients for Oral Formulations
Figure 2. Pharmaceutical Excipients for Oral Formulations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Excipients for Oral Formulations Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pharmaceutical Excipients for Oral Formulations Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pharmaceutical Excipients for Oral Formulations Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country/Region (2024)
Figure 10. Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type in 2025
Figure 14. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2020-2025)
Figure 15. Pharmaceutical Excipients for Oral Formulations Consumed in Hospital Pharmacies
Figure 16. Global Pharmaceutical Excipients for Oral Formulations Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 17. Pharmaceutical Excipients for Oral Formulations Consumed in Drug Stores
Figure 18. Global Pharmaceutical Excipients for Oral Formulations Market: Drug Stores (2020-2025) & (K Units)
Figure 19. Pharmaceutical Excipients for Oral Formulations Consumed in Retail Stores
Figure 20. Global Pharmaceutical Excipients for Oral Formulations Market: Retail Stores (2020-2025) & (K Units)
Figure 21. Pharmaceutical Excipients for Oral Formulations Consumed in E-Commerce
Figure 22. Global Pharmaceutical Excipients for Oral Formulations Market: E-Commerce (2020-2025) & (K Units)
Figure 23. Global Pharmaceutical Excipients for Oral Formulations Sale Market Share by Application (2024)
Figure 24. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application in 2025
Figure 25. Pharmaceutical Excipients for Oral Formulations Sales by Company in 2025 (K Units)
Figure 26. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Company in 2025
Figure 27. Pharmaceutical Excipients for Oral Formulations Revenue by Company in 2025 ($ millions)
Figure 28. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Company in 2025
Figure 29. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 32. Americas Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 33. APAC Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 34. APAC Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 35. Europe Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 36. Europe Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Revenue 2020-2025 ($ millions)
Figure 39. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country in 2025
Figure 40. Americas Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country (2020-2025)
Figure 41. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 42. Americas Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 43. United States Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Region in 2025
Figure 48. APAC Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Region (2020-2025)
Figure 49. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 50. APAC Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 51. China Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 55. India Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country in 2025
Figure 59. Europe Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Country (2020-2025)
Figure 60. Europe Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 61. Europe Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 62. Germany Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 63. France Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2020-2025)
Figure 70. Egypt Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Pharmaceutical Excipients for Oral Formulations Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Oral Formulations in 2025
Figure 76. Manufacturing Process Analysis of Pharmaceutical Excipients for Oral Formulations
Figure 77. Industry Chain Structure of Pharmaceutical Excipients for Oral Formulations
Figure 78. Channels of Distribution
Figure 79. Global Pharmaceutical Excipients for Oral Formulations Sales Market Forecast by Region (2026-2031)
Figure 80. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Platelet Aggregation Reagents Market Growth 2025-2031
US$ 3,660.00
December 2025
95 pages
Global Proton Therapy Solutions Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
100 pages
Global Tele-Intensive Care Unit Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
81 pages
Global Docosahexaenoic Acid (DHA) Market Growth 2025-2031
US$ 3,660.00
December 2025
107 pages
Global Chloramphenicol Ointments Market Growth 2025-2031
US$ 3,660.00
December 2025
97 pages
